Drugs News and Research

RSS

New study may lead to better treatments for prostate, ovarian, and breast cancers

Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.

21 May 2021

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.

21 May 2021

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.

21 May 2021

Intranasal COVID-19 therapeutic shows promise in preclinical trials

Researchers from the US and Denmark recently described a novel therapeutic option that targets the SARS-CoV-2 ribonucleic acid (RNA) using locked nucleic acid antisense oligonucleotides (LNA ASOs). They identified an LNA ASO that binds to the 5’ leader sequence of SARS-CoV-2 ORF1a/b. This disrupts a highly conserved stem-loop structure with nanomolar efficacy and inhibits viral replication in host cells.

20 May 2021

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

20 May 2021

Medicare negotiation could save billions of dollars in lower commercial health insurance costs by 2030

As Congress considers legislation to reform prescription drug pricing, a new analysis conducted by the West Health Policy Center and released by its Council for Informed Drug Spending Analysis (CIDSA) estimates that the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) could result in hundreds of billions of dollars in lower commercial health insurance costs by 2030.

20 May 2021

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.

20 May 2021

Seed money: Black entrepreneurs hope pandemic gardening boom will grow healthier eating

Ietef Vita had planned to spend most of 2020 on the road, promoting "Biomimicz," the album the rapper had released on his #plantbasedrecords label in January.

20 May 2021

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

A new study has been published in Small, which has combined in silico and in vitro analysis to examine if graphene oxide (GO) sheets have an inhibitory effect against SARS‐CoV‐2 surface proteins.

20 May 2021

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Scientists don't fully understand what causes Alzheimer's disease, but they have a primary suspect.

20 May 2021

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time by a third.

20 May 2021

Study could serve as guidepost for developing new therapies for Alzheimer's disease

In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta--the neurotoxin believed to be at the root of Alzheimer's disease (AD)--forms in axons and related structures that connect neurons in the brain, where it causes the most damage.

20 May 2021

Scientists use anti-psychotics to treat flies displaying behavioral problems linked to schizophrenia-associated genes

Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.

20 May 2021

The effects of SARS-CoV-2 vaccination on pregnancy and birth

The severe impact of this infection has given rise to a study by Theiler et al. (2021), which investigated the effects of SARS-CoV-2 vaccination in pregnancy in order to examine the protection it could provide to combat the infection.

19 May 2021

Study may lead to new treatments for a wide range of neurological conditions

New research published today sheds important light on how the production of a key protein in the brain is controlled, which could pave the way for new treatments for a wide range of neurological conditions.

19 May 2021

Potential immunotherapy may improve cognitive and behavioral functions after stroke

Specialized immune cells that accumulate in the brain in the days and weeks after a stroke promote neural functions in mice, pointing to a potential immunotherapy that may boost recovery after the acute injury is over, University of Pittsburgh School of Medicine neurologists found.

19 May 2021

Drugs News and Research

New study may lead to better treatments for prostate, ovarian, and breast cancers

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Intranasal COVID-19 therapeutic shows promise in preclinical trials

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

Medicare negotiation could save billions of dollars in lower commercial health insurance costs by 2030

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Seed money: Black entrepreneurs hope pandemic gardening boom will grow healthier eating

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Study could serve as guidepost for developing new therapies for Alzheimer's disease

Scientists use anti-psychotics to treat flies displaying behavioral problems linked to schizophrenia-associated genes

The effects of SARS-CoV-2 vaccination on pregnancy and birth

Study may lead to new treatments for a wide range of neurological conditions

Potential immunotherapy may improve cognitive and behavioral functions after stroke

Parental use of cannabis impacts how teens think about cannabis use

Researchers use base editing to sustainably lower high LDL cholesterol levels

Researchers develop integrative approach to better understand the origins of Parkinson's disease

Virtual analysis identifies a potential natural inhibitor of SARS-CoV-2 Nsp15

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News